Download FREE Report Sample
Download Free sampleOral solid dosage forms are the most commonly used pharmaceuticals to treat various disease conditions. Oral solid dosage forms are cost-effective and easy to manufacture in comparison with other dosage forms. They offer significant benefits to manufacturers such as trouble free packaging and transportation and increased chemical and physical stability. Oral solids offer many advantages to patients as well.
Oral Solid Dosage Pharmaceutical Formulation Market contains market size and forecasts of Oral Solid Dosage Pharmaceutical Formulation in Global, including the following market information:
Global Oral Solid Dosage Pharmaceutical Formulation Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Oral Solid Dosage Pharmaceutical Formulation market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Immediate Release Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Oral Solid Dosage Pharmaceutical Formulation include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Gilead, Merck, Novartis, Pfizer, AbbVie and Boehringer Ingelheim. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Oral Solid Dosage Pharmaceutical Formulation companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oral Solid Dosage Pharmaceutical Formulation Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Oral Solid Dosage Pharmaceutical Formulation Market Segment Percentages, by Type, 2021 (%)
Immediate Release
Extended Release
Others
Global Oral Solid Dosage Pharmaceutical Formulation Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Oral Solid Dosage Pharmaceutical Formulation Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacy
Retail Pharmacy
Drug Stores
Others
Global Oral Solid Dosage Pharmaceutical Formulation Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Oral Solid Dosage Pharmaceutical Formulation Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oral Solid Dosage Pharmaceutical Formulation revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Oral Solid Dosage Pharmaceutical Formulation revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Gilead
Merck
Novartis
Pfizer
AbbVie
Boehringer Ingelheim
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
